May 17, 2023 Comments Off on New patent for Incyte Corp drug PEMAZYRE Posted in: Patent Added Annual Drug Patent Expirations for PEMAZYRE Pemazyre is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent for Incyte Corp drug PEMAZYRE appeared first on DrugPaten…
May 17, 2023 Comments Off on New patent for Azurity drug KONVOMEP Posted in: Patent Added Annual Drug Patent Expirations for KONVOMEP Konvomep is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Azurity drug KONVOMEP appeared first on DrugPate…